Table 4.
Multiple linear regression model evaluating the effects of GCH1 SNPs on chronic pain in SCD
| Additive |
Dominant |
Recessive |
||||
|---|---|---|---|---|---|---|
| B (95% CI)a | p-value | B (95% CI)a | p-value | B (95% CI)a | p-value | |
| rs752688 | 1.51 (−3.13, 6.15) | 0.521 | 1.81 (−3.80, 7.41) | 0.524 | 1.95 (−10.58, 14.48) | 0.758 |
| rs3783641 | 1.65 (−2.20, 5.50) | 0.397 | 2.57 (−3.11, 8.24) | 0.372 | 1.59 (−5.49, 8.67) | 0.657 |
| rs4411417 | 0.47 (−3.84, 4.78) | 0.829 | 0.96 (−4.32, 6.24) | 0.719 | −1.16 (−12.51, 10.18) | 0.839 |
| rs8007267 | −3.76 (−7.28, −0.24) | 0.037 | −5.61 (−10.37, −0.85) | 0.021 | −3.03 (−10.42, 4.36) | 0.419 |
| rs10483639 | 3.23 (−0.27, 6.72) | 0.070 | 3.56 (−1.33, 8.45) | 0.152 | 5.46 (−1.48, 12.40) | 0.122 |
Unstandardized regression coefficient and 95% CI. Regression models are adjusted for age, sex, and sickle cell type.